Azitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders’ Equity Requirements

Reuters10-04

<a href="https://laohu8.com/S/AZTR">Azitra Inc</a>. Receives NYSE American Non-Compliance Notice Over Stockholders' Equity Requirements

Azitra Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003(a)(ii) of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016887), on October 03, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2572354186?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-04 04:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572354186","market":"us","top_or_hot":-1,"title":"Azitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders’ Equity Requirements","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AZTR\">Azitra Inc</a>. Receives NYSE American Non-Compliance Notice Over Stockholders' Equity Requirements\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Azitra Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003(a)(ii) of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016887), on October 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Azitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders’ Equity Requirements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAzitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders’ Equity Requirements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-04 04:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AZTR\">Azitra Inc</a>. Receives NYSE American Non-Compliance Notice Over Stockholders' Equity Requirements\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Azitra Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003(a)(ii) of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016887), on October 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL6ZFBPM:1","article_id":"2572354186","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572354186","pubTimestamp":1759525181,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Azitra Inc. , a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003 of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","AZTR":"Azitra Inc"},"translate_title":"Azitra Inc.收到纽约证券交易所美国公司关于股东权益要求的不合规通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZTR":0.9},"content_text":"Azitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders' Equity Requirements\n    \n\n        Azitra Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003(a)(ii) of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016887), on October 03, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2572354186","isCrawlerRequest":true}